Huntington’s gene therapy research has reached a turning point, expert says
An expert involved in the first successful gene therapy trial for Huntington's Disease discusses the trial results and challenges with the FDA.
Cell & Gene Therapy
Calls for change as access to cell and gene therapies in the Netherlands falls short
JPM26: Solid Biosciences banks on its AAV capsid to catalyse gene therapy success
Big pharma and investors re-engage in CGTs and race to scale
Investors bet on newer technology and indications for CGTs
Metagenomi culls 25% of its workforce and replaces CEO in reshuffle
FDA halts uniQure’s plans for Huntington’s disease gene therapy
Sartorius to invest $3m for minority share in biotech start-up Nanotein
